CHICAGO--(BUSINESS WIRE)--Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to ...
Is the internet losing its soul? A collaborative study by UC Riverside computer and social scientists suggests so. As ...
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced the acquisition of a majority stake in ...
One of the aims of anthropology is to promote human self-understanding, that is, to activate a process of awareness of the existential and cultural dynamics we experience. This is a liberating process ...
Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics. The ...
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...